A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

clinical trial

A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057 is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02916537

P6099clinical trial phasephase I clinical trialQ5452194
P17countryUnited States of AmericaQ30
P582end time2017-08-28
P921main subjectmetastatic prostate carcinomaQ55779807
P2899minimum age18
P1132number of participants20
P859sponsorCancer Targeted TechnologyQ30286547
P580start time2016-09-01
P8363study typeinterventional studyQ78089383
P1476titleA Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057, a Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA)

Search more.